Pure Global
NCT06062511

Poplar-type Propolis Dry Extract ESIT12 : Nutrikinetic and Bioavailability Studies

Evaluation of Nutrikinetic and Bioavailability of Phenolic Compounds From ESIT12, a Poplar-type Propolis Dry Extract
Fytexia·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Nutrition, Healthy
Drug/Device/Intervention
ESIT12 D
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Fytexia
Location
Guadalupe, Spain
Timeline & enrollment
Phase
N/A
Start date
Jul 22, 2023
End date
Oct 06, 2023
Enrollment
10 participants
Primary outcome

Change in plasma area under the curve (AUC) of phenolic metabolites after acute ingestion of the supplement/placebo,Change in plasma maximal concentration (Cmax) of phenolic metabolites after acute ingestion of the supplement/placebo,Change in plasma time to reach maximal concentration (Tmax) of phenolic metabolites after acute ingestion of the supplement/placebo,Change in urine area under the curve (AUC) phenolic metabolites excretion after acute ingestion of the supplement/placebo,Change in urine maximal concentration (Cmax) phenolic metabolites excretion after acute ingestion of the supplement/placebo,Change in urine time to reach maximal concentration (Tmax) phenolic metabolites excretion after acute ingestion of the supplement/placebo

Summary

The aim of this study is to investigate phenolic compounds from ESIT12, a poplar-type
 propolis ingredient, bioavailability and nutrikinetics by measuring urinary excretion and
 metabolic profile over 48h by means of high-performance liquid chromatography coupled with
 tandem mass spectrometry (HPLC-MS/MS). The study follows a cross-over, double-blind,
 randomized and placebo control design on 10 healthy subjects.

ICD-10 classifications
Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulMalnutritionObesitySequelae of malnutrition and other nutritional deficienciesNutritional deficiency, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06062511
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06062511 through Pure Global AI's free database. This phase not specified trial is sponsored by Fytexia and is currently Recruiting. The study focuses on Nutrition, Healthy. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.